# A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors

> **NCT07014878** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing DCTY Biotech Co.,Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Colorectal Cancer
- Lung Cancer
- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** TCR-T cells

## Key facts

- **NCT ID:** NCT07014878
- **Lead sponsor:** Beijing DCTY Biotech Co.,Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-08
- **Final completion:** 2028-08
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07014878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07014878, "A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07014878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*